CONDITION

Multicentric Lymphoma in Dogs

Multicentric lymphoma is a condition in which lymphocytes—white blood cells that normally patrol the body as part of the immune system—begin to multiply in an uncontrolled way within the lymph nodes. These nodes, which sit at junctions throughout the body, become visibly enlarged. In dogs, this form of lymphoma tends to affect multiple node groups at once, which is why it carries the name multicentric. Owners often first notice firm, painless swellings under the jaw, in front of the shoulders, or behind the knees. The dog may otherwise seem well in the early stages, or there may be quieter signs such as reduced appetite, weight loss, or a general sense that energy has dipped. Because the nodes themselves are not usually tender, the swelling can be present for some time before it prompts concern. This page explores what these swellings may signal, what is happening within the lymphatic system, how the condition is investigated through examination and laboratory work, and the range of approaches that exist once a picture has formed. The goal is orientation, not instruction—understanding the landscape so that conversations with your veterinary team can be as clear and grounded as possible.

Why this matters now

Multicentric lymphoma in dogs tends to appear in middle-aged to older animals, with most cases diagnosed between six and nine years of age. Certain breeds—including Golden Retrievers, Boxers, Bullmastiffs, and Scottish Terriers—appear more frequently in clinical records, though the condition can arise in any breed or crossbreed. There is no single environmental trigger that has been conclusively identified, and the reasons why lymphocytes begin to proliferate in this uncontrolled way remain an area of active investigation.

The course of multicentric lymphoma is variable, but without intervention it often progresses over a period of weeks to a few months. Some dogs remain outwardly comfortable in the early weeks, whilst others may show a more rapid decline in energy, appetite, or body condition. The pace can differ markedly between individuals, influenced by factors that are not always apparent at the time of diagnosis.

Signals & patterns

Early signals

Firm swellings under the jaw

The submandibular lymph nodes, which sit beneath the lower jaw on either side, may become noticeably enlarged. The swellings are typically firm, smooth, and painless to the touch, so the dog often shows no discomfort when the area is examined.

Lumps in front of the shoulders

The prescapular nodes, located just in front of the shoulder blades, can become palpable as distinct lumps beneath the skin. Owners sometimes notice these when stroking or grooming, particularly in short-coated breeds where the contours are easier to feel.

Reduced appetite or selective eating

Some dogs begin to turn away from meals or eat less enthusiastically than usual, without any obvious sign of nausea or distress. The change can be subtle at first, sometimes attributed to weather, routine, or simply a mood shift.

Quieter energy levels

A dog may seem less inclined to initiate play, may lag slightly on walks, or may choose to rest more often during the day. The shift is often gradual, which can make it difficult to pinpoint when it began.

Weight loss despite stable routine

Body condition may decline even when diet and activity have not changed. The loss tends to be slow and can be masked by a thick coat or by the owner's daily familiarity with the dog's shape.

Later signals

Swelling behind the knees

The popliteal nodes, situated in the hollow behind the hind legs, may enlarge as more lymphoid tissue becomes involved. These nodes are often easier to feel than to see, particularly in dogs with heavier build or longer fur.

Breathing changes or cough

If lymph nodes within the chest become enlarged, they may press against airways or interfere with normal lung expansion. This can lead to a persistent cough, faster breathing, or reluctance to settle comfortably when lying down.

Digestive signs

In some dogs, lymphoid tissue within the gastrointestinal tract becomes involved, leading to vomiting, diarrhoea, or a more profound reluctance to eat. These signs can emerge later in the course or may occasionally be the first indication that something has shifted.

General malaise or withdrawal

A dog may become less interactive, seek out quiet corners, or show less interest in household activity. The shift in demeanour can be subtle and is sometimes mistaken for ageing or mood, rather than a signal of underlying change.

Click to read about the biological mechanisms

How this is usually investigated

Investigation typically begins with a physical examination, during which enlarged lymph nodes are palpated and their size, texture, and distribution noted. The history—appetite, energy, weight changes—helps to sketch the broader clinical picture. From there, sampling of the affected tissue is usually needed to confirm what the swelling represents, and blood tests may be used to assess how other organs are functioning and whether the malignant cells have entered the circulation.

Fine-needle aspiration of lymph nodes

Purpose: A needle is passed into an enlarged node to collect a small sample of cells, which are then examined under a microscope. This can often reveal the presence of a uniform population of abnormal lymphocytes and provide a preliminary indication of lymphoma.
Considerations: The sample obtained is small, and whilst it can be highly suggestive, it does not always capture the full architecture of the tissue. In some cases, a larger biopsy may be needed to confirm the diagnosis or to classify the subtype of lymphoma more precisely.

Histopathology of lymph node biopsy

Purpose: A wedge or whole node is removed surgically and examined in detail, preserving the internal structure. This allows pathologists to classify the lymphoma by cell type and grade, which can inform expectations about behaviour and response to treatment.
Considerations: Biopsy requires a short general anaesthetic and is more invasive than fine-needle aspiration. It is often reserved for cases where the diagnosis is uncertain or where detailed classification will influence the choice of management approach.

Blood tests (haematology and biochemistry)

Purpose: Blood samples are analysed to check organ function—particularly liver and kidneys—and to look for evidence of malignant lymphocytes circulating in the bloodstream. These tests also help identify complications such as anaemia or elevated calcium, which can occur in some cases of lymphoma.
Considerations: Blood tests provide context rather than diagnosis; many dogs with multicentric lymphoma have entirely normal blood results at presentation. The presence of circulating lymphoma cells or biochemical abnormalities can influence prognosis but is not seen in every case.

Imaging (radiography and ultrasonography)

Purpose: Chest and abdominal imaging may be used to assess whether internal lymph nodes, the liver, the spleen, or other organs are enlarged or structurally altered. This helps to map the extent of disease within the body.
Considerations: Imaging does not confirm lymphoma on its own, but it can reveal how widespread the changes are and whether there are features that might complicate treatment, such as fluid accumulation or compression of nearby structures.

Bone marrow aspiration

Purpose: A sample of bone marrow is taken, usually from the hip or shoulder, to determine whether malignant lymphocytes have infiltrated the marrow. This can influence staging and, in some cases, prognosis.
Considerations: Bone marrow sampling is not performed in every case, and the decision to pursue it depends on the broader clinical picture and whether the result would alter management. The procedure is brief but does require sedation or anaesthesia.

Options & trade-offs

Management of multicentric lymphoma is shaped by the individual dog's circumstances, the owner's priorities, and the practical realities of treatment delivery. There is no single pathway that suits every case. Some approaches focus on extending time whilst maintaining a good quality of life, others on monitoring comfort and adjusting care as the condition evolves. The combination chosen often reflects what is feasible and tolerable for both dog and household.

Multi-agent chemotherapy protocols

These protocols use a rotating sequence of chemotherapy drugs, typically administered over several months, with the aim of inducing remission—a period during which the lymph nodes return to a more normal size and clinical signs recede. The most widely used protocol is known as CHOP, which combines four different drugs given at intervals, usually on an outpatient basis. Dogs often tolerate chemotherapy better than humans, and side effects such as nausea or lethargy tend to be mild and short-lived, though they do occur.

Trade-offs: Treatment requires regular visits to the veterinary clinic, and there is a cumulative cost in both time and money. Response rates are often high, but remission is not usually permanent, and most dogs will eventually experience relapse. The duration of remission varies widely, and some dogs respond less well than others for reasons that are not always clear at the outset.

Single-agent chemotherapy

A single chemotherapy drug, such as lomustine or doxorubicin, may be used on its own, often on a less intensive schedule than multi-agent protocols. This approach can still induce remission in many cases and may be chosen when simplicity, cost, or the dog's tolerance of frequent visits is a consideration.

Trade-offs: Remission duration tends to be shorter on average than with multi-agent protocols, though individual variation is substantial. Single-agent treatment is less complex to coordinate and may suit households where travel to a referral centre is difficult or where the appetite for intensive monitoring is lower.

Prednisolone monotherapy

Prednisolone is a corticosteroid that can reduce lymph node size and improve appetite and energy in the short term. It is given orally at home and does not require the same frequency of clinic visits as chemotherapy. Some dogs experience a period of improved wellbeing lasting weeks to a few months.

Trade-offs: The duration of response is generally shorter than with chemotherapy, and there is concern that prior use of prednisolone may reduce the effectiveness of subsequent chemotherapy if that route is later chosen. Longer-term use of prednisolone can lead to side effects such as increased thirst, urination, appetite, and changes in coat quality.

Palliative and supportive care

This approach focuses on maintaining comfort and quality of life without pursuing remission. It may include medications to manage symptoms such as nausea or pain, adjustments to diet, and monitoring for changes in the dog's condition. The emphasis is on recognising when wellbeing is declining and responding in a measured way.

Trade-offs: Progression of the lymphoma continues, and the window during which the dog remains comfortable is typically shorter than with active treatment. For some owners and dogs, avoiding the stress and side effects of chemotherapy is a priority, and this approach aligns with that preference.

Common misconceptions

Misconception:

"Swollen lymph nodes always mean the dog is in pain or discomfort."

Reality:

The enlarged nodes themselves are usually painless, and many dogs with multicentric lymphoma remain bright and active in the early stages. Discomfort, when it arises, tends to be linked to other effects of the disease—such as nausea, weight loss, or involvement of internal organs—rather than the swelling itself. The external nodes can be quite large before the dog shows any outward sign of distress.

Misconception:

"Chemotherapy in dogs works the same way as in humans and will cause severe sickness and hair loss."

Reality:

Dogs metabolise chemotherapy drugs differently, and the doses used are generally lower relative to body weight, with the aim of preserving quality of life rather than achieving cure at any cost. Hair loss is uncommon except in breeds with continuously growing coats, and gastrointestinal upset, whilst possible, is usually mild and manageable. Most dogs continue to eat, play, and behave much as they did before treatment, with side effects limited to a day or two around each dose.

Misconception:

"Once lymphoma is diagnosed, there is nothing that can be done and decline will be rapid."

Reality:

Multicentric lymphoma is responsive to treatment in many cases, and remission—sometimes lasting months or longer—can be achieved with chemotherapy. Even without chemotherapy, the rate of progression varies, and some dogs remain comfortable for a meaningful period. The trajectory is not uniform, and the options available can be tailored to what the owner and veterinary team consider workable.

Related conditions

Lymphoma in Cats

Lymphoma in cats shares the same underlying process—uncontrolled multiplication of lymphocytes—but tends to present with different patterns of distribution and organ involvement. Understanding the differences in how this condition behaves across species can help contextualise the range of ways lymphoma may appear.

Cutaneous Lymphoma

Cutaneous lymphoma arises from the same cell type—lymphocytes—but remains localised to the skin rather than involving the lymph nodes throughout the body. Some dogs may develop skin involvement alongside or after multicentric disease, and the two forms can occasionally be seen in the same animal over time.

Splenic Lymphoma

Splenic lymphoma represents lymphoma that primarily affects the spleen, an organ rich in lymphatic tissue. In multicentric disease, the spleen may also be involved, and distinguishing where the disease began or which organs are most affected can shape the picture that emerges during investigation.

Hemangiosarcoma

Haemangiosarcoma is another cancer that can cause generalised illness and internal organ involvement in dogs, and the two conditions may occasionally be considered alongside one another when investigating unexplained weight loss, lethargy, or internal masses. The biological behaviour and cells of origin differ, but both can present with overlapping signs early on.

Canine Parvovirus

Canine parvovirus can cause severe suppression of the immune system and changes in white blood cell populations, and dogs undergoing chemotherapy for lymphoma may be at heightened risk of infection if exposed. The connection is one of vulnerability rather than shared cause, but both conditions involve significant changes in immune cell populations.

Understanding how the condition is investigated and what the range of management options involves can help to clarify what questions may be useful in a clinical conversation. There may be value in exploring how other conditions affecting the lymphatic system present, or in considering the broader context of immune function and ageing within the longevity pillar. The path forward is individual, and the shape of that path often becomes clearer once the extent of disease and the dog's response to initial interventions are known.